Nimodipine for treatment of primary thunderclap headache
- 27 April 2004
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 62 (8), 1414-1416
- https://doi.org/10.1212/01.wnl.0000120669.85649.77
Abstract
Eleven patients with primary thunderclap headache (TCH) were treated with oral nimodipine 30 to 60 mg every 4 hours or IV nimodipine 0.5 to 2 mg/h if the oral regimen failed or images showed cerebral vasospasm. With oral nimodipine, headache did not recur in the nine patients without vasospasm. IV nimodipine was given in two patients with vasospasm, including one who developed ischemic stroke. Nimodipine may be effective for TCH. Vasospasm may warrant IV nimodipine.Keywords
This publication has 9 references indexed in Scilit:
- Bathing Headache: A Variant of Idiopathic Thunderclap HeadacheCephalalgia, 2003
- Reversible Segmental Cerebral Vasoconstriction (Call-Fleming Syndrome): the Role of Calcium AntagonistsCephalalgia, 2003
- Reversible Segmental Cerebral Vasoconstriction (Call-Fleming Syndrome): Are Calcium Channel Inhibitors A Potential Treatment Option?Cephalalgia, 2003
- Can Noninvasive Imaging Accurately Depict Intracranial Aneurysms? A Systematic ReviewRadiology, 2000
- Recurrent Thunderclap Headache Associated With Reversible Intracerebral Vasospasm Causing StrokeCephalalgia, 2000
- Nonaneurysmal Thunderclap Headache with Diffuse, Multifocal, Segmental, and Reversible VasospasmCephalalgia, 1999
- Calcium antagonists in patients with aneurysmal subarachnoid hemorrhageNeurology, 1998
- Clinical and Angiographic Features of Thunderclap HeadacheHeadache: The Journal of Head and Face Pain, 1995
- THUNDERCLAP HEADACHE: SYMPTOM OF UNRUPTURED CEREBRAL ANEURYSMThe Lancet, 1986